These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 25885284)

  • 1. Chemoresistance is associated with increased cytoprotective autophagy and diminished apoptosis in bladder cancer cells treated with the BH3 mimetic (-)-Gossypol (AT-101).
    Mani J; Vallo S; Rakel S; Antonietti P; Gessler F; Blaheta R; Bartsch G; Michaelis M; Cinatl J; Haferkamp A; Kögel D
    BMC Cancer; 2015 Apr; 15():224. PubMed ID: 25885284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of BAG3 sensitizes bladder cancer cells to treatment with the BH3 mimetic ABT-737.
    Mani J; Antonietti P; Rakel S; Blaheta R; Bartsch G; Haferkamp A; Kögel D
    World J Urol; 2016 Feb; 34(2):197-205. PubMed ID: 26100943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum.
    Lian J; Wu X; He F; Karnak D; Tang W; Meng Y; Xiang D; Ji M; Lawrence TS; Xu L
    Cell Death Differ; 2011 Jan; 18(1):60-71. PubMed ID: 20577262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Bcl-2 homology domain 3 mimetic gossypol induces both Beclin 1-dependent and Beclin 1-independent cytoprotective autophagy in cancer cells.
    Gao P; Bauvy C; Souquère S; Tonelli G; Liu L; Zhu Y; Qiao Z; Bakula D; Proikas-Cezanne T; Pierron G; Codogno P; Chen Q; Mehrpour M
    J Biol Chem; 2010 Aug; 285(33):25570-81. PubMed ID: 20529838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-induced autophagy promotes gemcitabine resistance in human bladder cancer cells through hypoxia-inducible factor 1α activation.
    Yang X; Yin H; Zhang Y; Li X; Tong H; Zeng Y; Wang Q; He W
    Int J Oncol; 2018 Jul; 53(1):215-224. PubMed ID: 29693166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. -(-)Gossypol promotes the apoptosis of bladder cancer cells in vitro.
    Macoska JA; Adsule S; Tantivejkul K; Wang S; Pienta KJ; Lee CT
    Pharmacol Res; 2008; 58(5-6):323-31. PubMed ID: 18840529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AT-101 simultaneously triggers apoptosis and a cytoprotective type of autophagy irrespective of expression levels and the subcellular localization of Bcl-xL and Bcl-2 in MCF7 cells.
    Antonietti P; Gessler F; Düssmann H; Reimertz C; Mittelbronn M; Prehn JH; Kögel D
    Biochim Biophys Acta; 2016 Apr; 1863(4):499-509. PubMed ID: 26721623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma.
    Voss V; Senft C; Lang V; Ronellenfitsch MW; Steinbach JP; Seifert V; Kögel D
    Mol Cancer Res; 2010 Jul; 8(7):1002-16. PubMed ID: 20587533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine-Induced Autophagy Protects Human Lung Cancer Cells from Apoptotic Death.
    Wu HM; Shao LJ; Jiang ZF; Liu RY
    Lung; 2016 Dec; 194(6):959-966. PubMed ID: 27604425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BH3-mimetic gossypol-induced autophagic cell death in mutant BRAF melanoma cells with high expression of p21Cip¹.).
    Jang GH; Lee M
    Life Sci; 2014 Apr; 102(1):41-8. PubMed ID: 24625733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bcl-2-Beclin 1 interaction in (-)-gossypol-induced autophagy versus apoptosis in prostate cancer cells.
    Lian J; Karnak D; Xu L
    Autophagy; 2010 Nov; 6(8):1201-3. PubMed ID: 20930561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy inhibition enhances pan-Bcl-2 inhibitor AT-101-induced apoptosis in non-small cell lung cancer.
    Mei H; Lin Z; Wang Y; Wu G; Song Y
    Neoplasma; 2014; 61(2):186-92. PubMed ID: 24299314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with gossypol reveals synergism against gemcitabine resistance in cancer cells with high BCL-2 expression.
    Wong FY; Liem N; Xie C; Yan FL; Wong WC; Wang L; Yong WP
    PLoS One; 2012; 7(12):e50786. PubMed ID: 23226540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical studies of apogossypolone, a novel pan inhibitor of bcl-2 and mcl-1, synergistically potentiates cytotoxic effect of gemcitabine in pancreatic cancer cells.
    Banerjee S; Choi M; Aboukameel A; Wang Z; Mohammad M; Chen J; Yang D; Sarkar FH; Mohammad RM
    Pancreas; 2010 Apr; 39(3):323-31. PubMed ID: 19823097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAG3 Overexpression and Cytoprotective Autophagy Mediate Apoptosis Resistance in Chemoresistant Breast Cancer Cells.
    Das CK; Linder B; Bonn F; Rothweiler F; Dikic I; Michaelis M; Cinatl J; Mandal M; Kögel D
    Neoplasia; 2018 Mar; 20(3):263-279. PubMed ID: 29462756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BECN1 and BIM interactions with MCL-1 determine fludarabine resistance in leukemic B cells.
    Sharma A; Singh K; Mazumder S; Hill BT; Kalaycio M; Almasan A
    Cell Death Dis; 2013 May; 4(5):e628. PubMed ID: 23681223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL.
    Bauer JA; Trask DK; Kumar B; Los G; Castro J; Lee JS; Chen J; Wang S; Bradford CR; Carey TE
    Mol Cancer Ther; 2005 Jul; 4(7):1096-104. PubMed ID: 16020667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proapoptotic protein Smac mediates apoptosis in cisplatin-resistant ovarian cancer cells when treated with the anti-tumor agent AT101.
    Hu W; Wang F; Tang J; Liu X; Yuan Z; Nie C; Wei Y
    J Biol Chem; 2012 Jan; 287(1):68-80. PubMed ID: 22052903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsp90 inhibitor 17-AAG sensitizes Bcl-2 inhibitor (-)-gossypol by suppressing ERK-mediated protective autophagy and Mcl-1 accumulation in hepatocellular carcinoma cells.
    Wang B; Chen L; Ni Z; Dai X; Qin L; Wu Y; Li X; Xu L; Lian J; He F
    Exp Cell Res; 2014 Nov; 328(2):379-87. PubMed ID: 25196280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells.
    Simonin K; Brotin E; Dufort S; Dutoit S; Goux D; N'diaye M; Denoyelle C; Gauduchon P; Poulain L
    Mol Cancer Ther; 2009 Nov; 8(11):3162-70. PubMed ID: 19887550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.